Home Antibody All anti-TMEM106A antibodies
Anti-TMEM106A Antibody Polyclonal
Also for TMEM106A (NM_145041)
|TMEM106A antibody was raised against a 14 amino acid synthetic peptide near the amino terminus of human TMEM106A.|
|WB, IHC, IF
||WB: 1 ug/ml, IHC: 5 ug/ml, IF: 5 ug/ml
|TMEM106A Antibody is supplied in PBS containing 0.02% sodium azide.|
|TMEM106A Antibody is affinity chromatography purified via peptide column.
|Homo sapiens transmembrane protein 106A (TMEM106A), transcript variant 2|
|FLJ50420; FLJ50717; FLJ77644; MGC182077; MGC182126; MGC20235|
|TMEM106A Antibody: Transmembrane protein 106A (TMEM106A) is a single-pass transmembrane protein that is closely related to TMEM106B, a protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual roles of TMEM106A and TMEM106B are still undetermined; however, as TMEM106B is involved in FTLD, it is possible that TMEM106A may also be a risk factor for FTLD. |
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of TMEM106A in A-20 cell lysate with TMEM106A antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.
Immunohistochemistry of TMEM106A in mouse brain tissue with TMEM106A antibody at 5 ug/mL.
Immunofluorescence of TMEM106A in mouse brain tissue with TMEM106A antibody at 20 ug/mL.